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ABSTRACT 1 
A major hurdle in producing a useful probiotic food product is bacterial survival 2 
during storage and ingestion. The aim of this study was to test the effect of γ-3 
PGA immobilisation on the survival of probiotic bacteria when stored in acidic 4 
fruit juice. Fruit juices provide an alternative means of probiotic delivery, 5 
especially to lactose intolerant individuals. In addition, the survival of γ-PGA-6 
immobilised cells in simulated gastric juice was also assessed. Bifidobacteria 7 
strains (B. longum, B. breve), immobilised on 2.5 % γ-PGA, survived 8 
significantly better (P < 0.05) in orange and pomegranate juice for 39 and 11 9 
days respectively, compared to free cells. However, cells survived significantly 10 
better (P < 0.05) when stored in orange juice compared to pomegranate juice. 11 
Moreover, both strains, when protected with 2.5 % γ-PGA, survived in simulated 12 
gastric juice (pH 2.0) with a marginal reduction (<0.47 log CFU/ml) or no 13 
significant reduction in viable cells after four hours, whereas free cells died 14 
within two hours. In conclusion, this research indicates that γ-PGA can be used 15 
to protect Bifidobacteria cells in fruit juice, and could also help improve the 16 
survival of cells as they pass through the harsh conditions of the gastrointestinal 17 
tract (GIT). Following our previous report on the use of γ-PGA as a 18 
cryoprotectant for probiotic bacteria, this research further suggest s that γ-PGA 19 
could be used to improve probiotic survival during the various stages of 20 
preparation, storage and ingestion of probiotic cells.   21 
 22 
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1.  INTRODUCTION 1 
The gastrointestinal tract (GIT) of humans is inhabited by a vast community of 2 
microbes representing well over 400 different microbial species, comprising 10
14
 3 
bacterial cells which exceeds the number of eukaryotic cells in the human body 4 
by a factor of 10 (Cani and Delzenne, 2009; Turnbaugh et al., 2007). For proper 5 
functioning of the GIT, it is important to maintain a balance of the different 6 
organisms. This appears to be difficult due to various factors such as eating 7 
patterns, improper use of antibiotics and stress, all of which tend to favour the 8 
rise of pathogenic microorganisms and a decrease in beneficial microbes (Fooks 9 
and Gibson, 2002; McFarland and Dublin, 2008). Therefore, to maintain balanced 10 
microbial consortia in the GIT, beneficial organisms are often administered to 11 
individuals as ‘probiotic organisms’. Probiotic organisms are defined as live 12 
organisms that confer health benefits to the host when administered in adequate 13 
amount (Reid et al., 2003). Most of the studied probiotic organisms include 14 
different strains of Lactobacillus and Bifidobacteria (Theodorakopoulou et al., 15 
2013). There are numerous health and nutritional benefits of probiotic organisms 16 
including the promotion of healthy digestive system, prevention of urinary tract 17 
infection, prevention of cancer and promotion of immune response (Allaker and 18 
Douglas, 2009; Bertazzoni et al., 2013; Patel and Goyal, 2013; Prakash et al., 19 
2011).  20 
 21 
Although there is a lot of evidence in the literature on the benefits of probiotics, 22 
there remains an uncertainty about the usefulness of these bacteria. This 23 
uncertainty often stems from lack of reproducibility of the data, a possible 24 
consequence of insufficient/inconsistent numbers of live bacteria reaching the 25 
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intestine. The benefits of probiotic bacteria are largely dependent on their ability 1 
to survive, colonize and multiply in the host (Anal and Singh, 2007; Burgain et 2 
al., 2011). It has been determined that a food with health claims from the 3 
addition of probiotics must contain at least 10
6
 CFU/ml of viable bacteria 4 
(Kailasapathy and Chin, 2000). Probiotics are usually administered or added to 5 
food products as dry cultures prepared mainly by freeze drying, as they are easier 6 
to handle when freeze dried. However, the procedures used to prepare freeze 7 
dried probiotic bacteria are detrimental to cell structure and viability (Saarela et 8 
al., 2005). Furthermore, the nature of the food or drink product into which the 9 
probiotic microorganism is introduced is generally limited to milk based products 10 
which maintain a weak acidic environment tolerated by the microorganisms. 11 
Even under these conditions, shelf life is still restricted. In addition, there is a 12 
considerable loss in viability of probiotic bacteria when they encounter the very 13 
acidic conditions of the stomach and high bile concentration in the small 14 
intestine. The mechanism of probiotic response to bile salt and stimulated gastric 15 
juice has previously been described (Sánchez et al., 2007; Sanchez et al., 2005). 16 
Therefore, there remains a need to improve the viability of probiotic 17 
microorganisms as they pass through the freeze drying, storage and ingestion 18 
processes.   19 
 20 
Also, for individuals with lactose intolerance or milk protein allergy, it would be 21 
useful to broaden the range of products into which probiotic bacteria could be 22 
introduced, for example, fruit juices. Although fruit juices provide a less suitable 23 
environment for survival of probiotic bacteria (Saarela et al., 2006), which is 24 
most likely due to the low pH values of fruit juices compared to dairy products, 25 
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the innovation of suitable technologies to improve bacterial survival in fruit juice 1 
will be a beneficial discovery. This will not only bring about an alternative to  2 
probiotic delivery to lactose intolerant individuals, but it may also help the 3 
bacteria to endure the harsh acidic conditions of the stomach, thus improving the 4 
survival of ingested probiotics. 5 
 6 
Immobilisation and encapsulation of probiotic bacteria in di fferent materials are 7 
present technologies used to improve the survival of probiotic cells during 8 
storage and ingestion. Although both terms (immobilisation and encapsulation) 9 
are often used interchangeably in literature, the latter refers to the formation of a 10 
continuous coating around an inner matrix wholly contained within the wall of 11 
the capsule, while the former involves trapping of the cells either within or 12 
throughout the matrix. In the former, a small part of the cell may be exposed at 13 
the surface while in the latter the cells are completely surrounded within a 14 
capsule (Kailasapathy, 2002; Vidhyalakshmi et al., 2009). Methods used for the 15 
immobilisation of probiotic cells include spray drying, freeze drying, extrusion 16 
and phase separation (Kailasapathy, 2002; Lozinsky et al., 2003; Vidhyalakshmi 17 
et al., 2009). Commonly used immobilisation materials include alginate, xanthan, 18 
carrageenan and phthalate cellulose (Doleyres and Lacroix, 2005). Although 19 
these materials have been shown to be useful in protecting cells during different 20 
stages of probiotic food preparation and ingestion, there remains the need to 21 
develop new materials which can protect cells not only during preparation, 22 
storage or ingestion but also throughout the process from preparation of the 23 
probiotic food product to its safe delivery to the host.   24 
 25 
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We have earlier shown that immobilising probiotic bacteria in poly-γ-glutamic 1 
acid (γ-PGA) produced from a non-toxic microbial species of Bacillus can 2 
improve the survival of these organisms during freeze drying (Bhat et al., 2013). 3 
To continue with our investigation, this research was designed to study the 4 
protective effect of γ-PGA on probiotic bacterial survival in two types of fruit 5 
juices (orange and pomegranate juice) and in simulated gastric juice. Two 6 
Bifidobacterium strains were selected as model probiotic microorganisms for this 7 
study, owing to their known susceptibility to low pH and various stress 8 
conditions (Russell et al., 2011). 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
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2. MATERIAL AND METHODS 1 
2.1 γ-PGA 2 
The sodium salt of γ-PGA (molecular weight – 257,000 Da) was produced using 3 
B. subtilis natto (ATCC 15245), following previously described methods (Kedia 4 
et al., 2010). 5 
 6 
2.2 Bacterial strains 7 
The probiotic bacterial strains used in this investigation were: Bifidobacterium 8 
longum NCIMB 8809 and Bifidobacterium breve NCIMB 8807. Strains were 9 
obtained from NCIMB as stock cultures and freeze-dried before storage at -20 10 
°C. Prior to their use, the cultures were revived aseptically and grown 11 
anaerobically on Bifidobacteria Selective Medium (BSM) Agar at 37 °C in jars 12 
using an atmosphere generation system (Oxoid Anaerogen
TM
) and an indicator 13 
strip. 14 
 15 
2.3 Media  16 
BSM (a selective and differential media for Bifidobacteria) agar/broth were used 17 
for growth and enumeration of Bifidobacteria in simulated gastric juice (SGJ) 18 
experiment (Nualkaekul et al., 2011). BSM broth/agar were purchased and 19 
prepared according to the manufacturer’s protocol (Sigma-Aldrich, U. K.). 20 
Phosphate buffered saline (PBS) obtained from Sigma-Aldrich was prepared by 21 
dissolving 1 tablet in 200 ml following manufacturer’s instructions. 22 
 23 
SGJ contained 2 g/l NaCl, 3.2 g/l pepsin powder and 20 ml of 1M HCl (British 24 
Pharmacopoeia Commission, 1993). The components were diluted in 900 ml 25 
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deionised water and after pH adjustment (pH 2.0), the volume was topped up to 1 1 
l. pH was adjusted using 1 M HCl or 1 M NaOH. This model solution was 2 
sterilized by passage through a sterile 0.2 µm syringe filter.  3 
 4 
2.4 Preparation of γ-PGA-immobilised cells 5 
Freeze dried γ-PGA protected cells were prepared as described previously (Bhat 6 
et al., 2013). Cells were initially grown in BSM and recovered as pellets by 7 
centrifugation, and then washed with PBS and suspended in 10 ml suspension of 8 
10% w/v γ-PGA. The cell/γ-PGA suspension was then incubated at room 9 
temperature for 1 hr and then at -80 ºC for 24 hrs. Subsequently, the samples 10 
were freeze dried (Edwards Freeze Dryer, Modulyo, UK) at  – 40 ºC and 5 mbar 11 
for 48 hrs (Bhat et al., 2013). 12 
 13 
2.5 Cell survival in fruit juices 14 
Fresh samples of commercially available orange juice (Tropicana orange juice, 15 
Pure Premium Smooth No Bits – 100% freshly squeezed orange juice) and 16 
pomegranate juice (POM Wonderful 100% Pomegranate juice)  were purchased from 17 
a local supermarket and used for the tests. No microbial growth was observed in 18 
overnight cultures of each juice at 37 °C under anaerobic conditions in BSM.The 19 
dry powder of γ-PGA-immobilised cells was suspended in 1 ml PBS and this 20 
suspension was added to 40 ml of the respective juice to give a final 21 
concentration of γ-PGA coated cells in fruit juice of 2.5 % (v/v). As control, non-22 
immobilised free cells were inoculated in BSM broth under the aforementioned 23 
conditions and the cell pellets were obtained after centrifugation and washing 24 
with PBS. The cell pellets were suspended in 1 ml PBS and these cell 25 
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suspensions (immobilised samples and control) were added to each juice and 1 
stored at 4 ºC. Samples were collected at day 0, 2, 4, 6, 8, 11, 13, 20, 28 and 39 2 
of storage for orange juice and at day 0, 2, 4, 6, 8, 11 and 13 for pomegranate 3 
juice. After appropriate dilution, 0.1ml aliquots from the dilutions were plated on 4 
BSM agar and incubated anaerobically at 37 ˚C for 48 hrs to assess the 5 
concentration (expressed as CFU/ml) of the free and immobilised probiotic cells 6 
in the respective fruit juice.  7 
 8 
2.6 Organic acid concentration of fruit juice 9 
Organic acid analysis was performed using an Agilent 1100 HPLC system to 10 
assess any changes in the organoleptic composition of the fruit juice.  A Prevail 11 
Organic Acid 5µm column with a UV detector was used for citric acid, malic 12 
acid, lactic acid, acetic acid and ascorbic acid analysis. A 25 mM KH2PO4 13 
solution (pH 2.5 adjusted with phosphoric acid) was used as the eluent. Before 14 
loading, the samples were filtered using 0.45 µm filters and diluted 10 fold  with 15 
deionised water. Standard curves were prepared using known concentrations of 16 
the chemicals to be analysed. 17 
 18 
2.7 Probiotic survival in simulated gastric juice 19 
The survival of the two Bifidobacterium strains (free and immobilised on γ-PGA) 20 
in SGJ was monitored for 4 hrs.  21 
 22 
The tests were carried out in an Electrotek Anaerobic Workstation , where a 23 
microaerophilic environment was maintained (10% CO2 and 5% O2) at 37 °C. 24 
This would also test the effect of γ-PGA on the survival of bacteria when 25 
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exposed to some oxygen just before ingestion. The cell concentration was 1 
measured at 0 hrs, 1 hr, 2 hrs, 3 hrs and 4 hrs for γ-PGA-immobilised and free 2 
cell. This was done by making appropriate dilution of samples up to 10
-8
 and 3 
plating them out on BSM agar. Plates were incubated anaerobically at 37 °C for 4 
48 hrs to assess the cell concentration at different incubation times in SGJ.   5 
 6 
2.8 Statistical analyses 7 
All experiments were performed in triplicate and results were analysed using 8 
Microsoft Excel 2010 and Graph Pad Prism 5. Two-factor ANOVA was used to 9 
analyse the differences in survival of B. breve and B. longum in either juices with 10 
respect to time while Student’s T tests were used to compare the acid 11 
concentration in the juices before and after treatment with immobilized and non -12 
immobilized probiotics. The Bonferroni multiple comparison test was used for 13 
non-parametric analysis of data to determine the difference between individual 14 
groups in a data set. A P. value ≤ 0.05 was considered to be statistically 15 
significant. 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
3. RESULTS 25 
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 1 
3.1 γ-PGA protection of probiotic cells in orange juice 2 
2.5 % γ-PGA-protected B. longum and B. breve were stored in orange juice for up 3 
to 39 days at 4 ˚C. The results are presented in figures 1 and 2 along with the 4 
control experiments with non-immobilised free cells. After 13 days of storage, a 5 
loss in viable cell concentration of around 4.0 log CFU/ml and 3.4 log CFU/ml 6 
was observed in free B. breve and B. longum cells, respectively. A complete loss 7 
in viability of free cells in orange juice was observed on day 20 of the 8 
experiment for both strains. In contrast, γ-PGA-immobilised B. breve and B. 9 
longum cells showed only around 0.5 log CFU/ml and 1.1 CFU/ml log reductions 10 
in viable cells, respectively, after 13 days of storage at 4 ºC. On day 39, viable 11 
counts of around 6.6 log CFU/ml and 6.5 log CFU/ml were observed for 12 
immobilised B. breve and B. longum cells respectively, indicating a reduction of 13 
approximately 2.1 log CFU/ml and 3.2 log CFU/ml, respectively (Figures 1 and 14 
2).  15 
 16 
3.2 γ-PGA protection of probiotic cells in pomegranate juice  17 
The results from the survival studies in pomegranate juice, carried out for up to 18 
13 days of storage at 4 
°
C, are presented in Figures 3 and 4. A complete loss in 19 
viability for free B. longum cells was observed on day 6. In comparison, a 20 
complete loss in viability of free B. breve cells was observed on day 2. Another 21 
notable observation was a very low viable cell concentration of both free B. 22 
longum (~4.8 log CFU/ml) and B. breve (~5.0 log CFU/ml) cells on day 0 of the 23 
experiment, which indicates that a significant proportion of the cells died 24 
immediately after they were introduced into the juice.  On the other hand, the 25 
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immobilised cells survived considerably better in the pomegranate juice than the 1 
free cells. Nevertheless, a loss in viable cell concentration of around 2.9 log 2 
CFU/ml and 2.1 log CFU/ml was observed for the γ-PGA-immobilised B. longum 3 
and B. breve cells after 2 days of storage, respectively. The cell concentration 4 
gradually declined until day 13 and day 11 with losses of around 5.5 log CFU/ml 5 
for B. longum and 4.0 log CFU/ml for B. breve, respectively. Both experiments 6 
were discontinued as the cell concentrations of both strains fell below the FAO 7 
recommended value of 6 – 7 log CFU/ml. 8 
 9 
3.3 pH and organic acid concentration of juices  10 
The pH of fresh orange juice, with no cells added was 3.91 (Table 1). This was 11 
reduced to 3.82 after 39 days of storage at 4 ºC. The pH of the orange juice 12 
containing free B. longum or B. breve was reduced to 3.71 and 3.65, respectively, 13 
after 39 days of storage. On the other hand, the pH of the orange juice containing 14 
γ-PGA immobilised B. longum or B. breve increased to 4.36 and 4.22, 15 
respectively, after 39 days storage (Table 1). For pomegranate juice, not much 16 
difference in the pH was observed between the fresh juice with no cells and juice 17 
containing free Bifidobacterium cells after 39 days of storage at 4 ºC. However, 18 
pomegranate juice containing γ-PGA immobilised cells showed an increase in pH 19 
of around 0.85 compared to fresh juice, resulting in a pH of around 4.05,  after 39 20 
days of storage. 21 
 22 
Fresh orange juice, without the presence of Bifidobacterium cells, contained 23 
around 425 mg/l of ascorbic acid and this concentration dropped to around 161 24 
mg/l after storage at 4 ˚C for 39 days (Table 2). Orange juice with free B. longum 25 
13 
 
and B. breve cells demonstrated a reduction in ascorbic acid concentration to 1 
around 79 mg/l and 173 mg/l, respectively, after 39 days of storage. Likewise, 2 
orange juice containing γ-PGA-immobilised B. longum or B. breve cells 3 
demonstrated a reduction in ascorbic acid concentration to around 71 mg/l and 4 
193 mg/l, respectively, after 39 days of storage at 4 ºC (Table 2).  5 
 6 
The concentrations of citric acid and malic acid in the fresh orange juice were 7 
around 9.9 g/l and 3.8 g/l respectively. After 39 days of storage the difference in 8 
concentration of citric and malic acid in orange juice without Bifidobacterium 9 
cells was not significantly different when compared to that of fresh juice (P > 10 
0.05). Similarly, in the orange juice with either free or γ-PGA immobilised B. 11 
longum or B. breve cells, there was no significant difference in the concentration 12 
of malic and citric acid compared to that of fresh juice (P > 0.05) (Table 2). 13 
 14 
The concentrations of citric, malic and ascorbic acids in pomegranate juice stored 15 
at 4 °C for 39 days are shown in Table 3. Contrary to the observations in orange 16 
juice, no reduction in the ascorbic acid concentration was observed in the 17 
pomegranate juice with free and γ-PGA-immobilised cells (Table 3). The 18 
concentration of citric and malic acid in the pomegranate juice with free and γ-19 
PGA-immobilised cells did not show any significant (P > 0.05) reduction either 20 
(Table 3).  21 
 22 
3.4 Protection of probiotic cells in simulated gastric juice 23 
The effect of 2.5% γ-PGA immobilisation on the survival of B. longum and B. 24 
breve in simulated gastric juice (up to 4 hrs at pH 2) was investigated in vitro and 25 
14 
 
the data are presented in Figure 5. It can be seen that immobilisation protected 1 
the Bifidobacterium strains, as a marginal (~ 0.5 log CFU/ml) but not significant 2 
reduction in viable cell concentration after 4 hrs (P > 0.05) was observed. In 3 
contrast, the free B. longum and B. breve cells showed a complete loss in 4 
viability within 2 hrs. Even after one hour in SGJ, the cell concentration of the 5 
free cells (around 4.0 – 4.2 log CFU/ml for both Bifidobacterium cells) was 6 
below the recommended FAO values (10
6
 – 107 CFU/ml) considered to be 7 
beneficial to the host.  8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
4. DISCUSSION  23 
Fruit juices are good candidates for the incorporation of probiotic bacteria, since 24 
they are rich in nutrients (Ding and Shah, 2008) and often have oxygen 25 
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scavenging agents, such as ascorbic acid, which promote anaerobic conditions  1 
that are important for the survival of certain lactic acid bacteria  and 2 
Bifidobacteria, commonly used as probiotics. In addition, fruit juices contain 3 
high amounts of sugars which could enhance the survival of the incorporated 4 
probiotic bacteria as they would serve as an energy source for maintenance of 5 
cellular activities (Delete). However, it is often seen that probiotic viability in 6 
fruit juices is hampered due to factors such as low pH and the presence of 7 
competing microorganisms (Granato et al., 2010). γ-PGA is a natural biopolymer 8 
that can be potentially incorporated into food as it is Generally Recognized As 9 
Safe (GRAS) by the FDA (Shyu and Sung, 2010) and has been shown from our 10 
previous research to have good cryoprotective properties for probiotic bacteria 11 
(Bhat et al., 2013). Among the various microorganisms used as probiotics, 12 
Bifidobacteria have attracted significant commercial interest over the years, as 13 
their beneficial health effects have been well documented, despite the fact that 14 
they are generally very sensitive to low pH conditions, either those in the food 15 
product or in the GIT (Cui et al., 2000). The aim of this work was to evaluate 16 
whether immobilisation of Bifidobacterium cells on γ-PGA, a GRAS polymer, 17 
can improve the survival of the cells in orange, pomegranate juice and simulated 18 
gastric juice. 19 
 20 
In orange juice, free cells of both Bifidobacterium species, showed complete loss 21 
of viability within 20 days (Figure 1, 2) with the number of cells going below the 22 
FAO value of 6 – 7 log CFU/ml (Kailasapathy and Chin, 2000; Kurmann and 23 
Rasic, 1991) on day 11 (< 5 log CFU/ml). In contrast, γ-PGA-immobilised cells 24 
survived well for 39 days in orange juice with viable cell concentrations of 6.48 25 
16 
 
log CFU/ml and 6.61 log CFU/ml for B. longum and B. breve respectively. In 1 
pomegranate juice, there was a complete loss in viable cell concentration of free 2 
B. longum cells within 6 days, with cell concentration reducing immediately upon 3 
introduction into the juice. This result was similar to that of B. breve, however, a 4 
complete loss in viability was observed after only 2 days of introducing free cells 5 
into the juice. This shows that B. longum survived better in pomegranate juice 6 
compared to B. breve. γ-PGA immobilised cells survived significantly better than 7 
free cells in pomegranate juice although not to the same extent as those in orange 8 
juice.  9 
 10 
These results have clearly shown the bacterial protective ability of γ-PGA in fruit 11 
juices. Although the complete mechanism of protection within the juice is not 12 
fully understood, one possible explanation would be the physical entrapment of 13 
the cells to the polymer matrix. Also, it is possible that some of the γ-PGA may 14 
have solubilised over time in the juice, as a pH of ~ 4.0 has previously been 15 
shown to result in over 50% disruption of the α-helical conformation of γ-PGA 16 
(Ho et al., 2006), thus leading to a higher pH level in both orange and 17 
pomegranate juice with γ-PGA-immobilized cells compared to juice with free 18 
cells or without any cells (Table 1). This increased pH may have created a better 19 
environment for the survival of the cells. However as the pH of the juice with γ-20 
PGA-immobilized cells remained below 4.5, the pH change of < 1 may not 21 
completely account for the increased survival as previous research has shown 22 
complete loss in cell growth of most probiotic cell at pH between 4.5 and 5.5 23 
with cell death at pH of 4.1 or below (Shah and Dave, 2002). Thus, physical 24 
entrapment within the γ-PGA matrix as well as increase in the pH of the juice 25 
17 
 
may both play important roles in the protection of probiotic cells in fruit juice by 1 
γ-PGA.   2 
 3 
B. longum encapsulated in Ca-alginate beads has previously been shown to 4 
survive 6 weeks in orange juice with a reduction in viable cell number of ~3.0 5 
log CFU/ml by the end of storage at 4 ˚C (Ding and Shah, 2008). In our 6 
experiment, γ-PGA immobilised cells showed a similar loss over a similar period. 7 
However, studies have shown that Ca-alginate is not effective in protecting cells 8 
in low pH conditions and that survival depends on various parameters such as 9 
alginate concentration and bead size (Anal and Singh, 2007; Chandramouli et al., 10 
2004; Hansen et al., 2002; Krasaekoopt et al., 2004; Lee and Heo, 2000; 11 
Mortazavian et al., 2008). Contrarily, our experiment showed that γ-PGA is not 12 
only effective in protecting cells in juice but can also protect  cells in low pH 13 
environments (Figure 5), thus making it a more desirable choice as a probiotic 14 
immobilisation material in fruit juices compared to Ca-alginate. In another study, 15 
B. breve protected with either polydextrose or a mixture of polydextrose and oat 16 
had a loss in viable cell number of ~ 6 Log CFU/ml within 20 days of incubation 17 
in a fruit juice with pH value of 3.8 (similar to that of orange juice used in this 18 
experiment) (Saarela et al., 2011). The researchers earlier showed a loss in viable 19 
cell number of ~ 5 Log CFU/ml of Lactobacillus rhamnosus protected with 20 
sucrose in apple juice for 4 weeks at 4 °C (Saarela et al., 2006). These results 21 
indicate that γ-PGA has more potential as an immobilisation material (with a cell 22 
loss of ~ 3 Log CFU/ml in fruit orange juice at 4 °C) for the protection of 23 
probiotic cells in juice when compared to polydextrose or sucrose.  24 
 25 
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A more recent experiment by Nualkaekul et al., showed that coating alginate 1 
bead encapsulated B. longum or L. plantorum with either chitosan, gelatin or 2 
glucomannan resulted in increased survival of the cells stored in either cranberry 3 
or pomegranate juice for 6 weeks at 4 °C (Nualkaekul et al., 2013). Depending on 4 
the coating material and the concentration used, they reported that a cell death of 5 
less than 1 Log CFU/ml could be achieved (Nualkaekul et al., 2013). Although 6 
alginate bead coating resulted in increased cell survival in pomegranate juice 7 
when compared to γ-PGA, the process of encapsulation is more demanding when 8 
compared to the freeze drying process used in the production of γ-PGA 9 
immobilised cells. Also, the cost of encapsulation and coating are higher when 10 
compared to the cost of preparation of freeze dried γ-PGA-immobilised cells. 11 
Furthermore, coating alginate beads caused an increased size (> 3.5mm) which is 12 
likely to affect the texture of juice considerably, compared to γ-PGA-13 
immobilized cells. This change in the texture of the juice may be unpleasant to 14 
consumers and thus may lead to reduced acceptance (Nualkaekul et al., 2013). 15 
Therefore, immobilising cells using γ-PGA could be a more acceptable and less 16 
intensive/costly means of protecting probiotic cells in fruit juice compared to 17 
coated alginate beads. Additionally, combining γ-PGA with other polymers may 18 
also increase the survival of immobilised probiotic cells and should be 19 
considered as a means of improving the use of γ-PGA as an immobilisation agent 20 
in probiotic protection (Delete).  21 
 22 
Comparing the Bifidobacteria survival results obtained from orange juice to that 23 
of pomegranate juice, it is clear that Bifidobacteria survived better in orange 24 
juice, with very poor survival recorded for unprotected Bifidobacteria cells in 25 
19 
 
pomegranate juice. Also, B. longum survived significantly better (P < 0.05) in 1 
pomegranate juice compared to B. breve. The poor survival of unprotected B. 2 
longum cells in pomegranate juice compared to orange juice has been 3 
demonstrated in other studies (Nualkaekul and Charalampopoulos, 2011; 4 
Nualkaekul et al., 2011), where B. longum viable cell concentration decreased by 5 
~8 log CFU/ml and ~0.8 log CFU/ml in pomegranate and orange juice 6 
respectively within 1 week of storage at 4 ˚C  (Delete).  The poor survival of 7 
Bifidobacteria in pomegranate juice compared to orange juice may be due to its 8 
higher acidity most likely due to the much higher level of citric and malic acid 9 
(Tables 2 and 3). This high acidity which is likely to have resulted in the sharp 10 
decrease in viability may also be responsible for the lack of oxidation of ascorbic 11 
acid by the cells. Thus, no reduction in the acid content was observed in 12 
pomegranate juice after 39 days compared to orange juice.  The higher ascorbic 13 
acid concentration in orange juice (Table 2) may also aid Bifidobacteria survival. 14 
Ascorbic acid is an oxygen scavenger (Janjarasskul et al., 2013) and helps 15 
promote anaerobic conditions which are ideal for Bifidobacteria growth and 16 
survival. This could account for better survival of Bifidobacteria in orange juice 17 
as these cells are known to be very sensitive to oxygen. In addition, pomegranate 18 
juice contains a high amount of polyphenolic compounds which have antioxidant 19 
and anti-microbial properties (Al-Zoreky, 2009; Chidambara Murthy et al., 2002; 20 
Johanningsmeier and Harris, 2011). 21 
 22 
This experiment showed that orange juice has more potential as a vehicle for the 23 
delivery of probiotics compared to pomegranate juice. However, t he addition of 24 
probiotics to pomegranate juice will help increase its present therapeutic 25 
20 
 
benefits, as it is known to contain several beneficial constituents including 1 
ellagic acid, punicic acid, flavonoids, anthocyanidins, anthocyanin, estrogenic 2 
flavonols and flavones (Devi et al., 2011). Thus, more research should be focused 3 
on the development of advanced technology to improve the survival of probiotics 4 
in pomegranate juice. One means of doing this could be combining γ-PGA with 5 
other biocompatible polymers such as polyglycerol sebactae (PGS)  (Delete). 6 
 7 
Apart from storage, another concern with regards to probiotic delivery is the 8 
survival of the bacteria during gastrointestinal tract transit where they encounter 9 
the gastric juice in the stomach as well as bile in the small intestine.  A large 10 
reduction in viability of probiotic bacteria has been demonstrated in the stomach, 11 
a region of high acidity (Cui et al., 2000; Su et al., 2011; Vasiljevic and Shah, 12 
2008). This study also found that free Bifidobacterium cells (B. longum and B. 13 
breve) died immediately with a 5 log CFU/ml reduction in cell concentration 14 
within 1 hr of incubation in simulated gastric juice and had reduced to 15 
undetectable levels within 2 hrs. Since γ-PGA is stable in acidic environments, 16 
and disintegrates in weaker acidic or neutral environments (Ho et al., 2006), it is 17 
a potential vehicle for the delivery of viable probiotic cells through the stomach 18 
environment. Results obtained from our experiment indicated that both γ-PGA-19 
immobilised B. longum and B. breve cells showed marginal or no loss in viable 20 
cell concentration over a 4 hrs period of incubation in simulated gastric juice.   21 
 22 
A comparison of γ-PGA protection of Bifidobacterium cells to other approaches 23 
such as alginate-human like collagen, alginate-poly-l-lysine and milk chocolate 24 
(Cui et al., 2000; Khalf et al., 2010; Possemiers et al., 2010; Su et al., 2011) in 25 
21 
 
simulated gastric juice (Table 4) shows that γ-PGA could offer better protection 1 
to probiotic cells in gastric juice. The protection is possibly due to the fact that γ-2 
PGA remains structurally stable in a low pH environment  and disintegrates as the 3 
pH increases to above 6 (Ho et al., 2006) thus providing protection to cells from 4 
the highly acidic environment. In a pH stability study (Ho et al., 2006), strong 5 
intra-molecular hydrogen bonding existed in γ-PGA at pH 2.0, as at that pH it 6 
formed a stable compact α-helix conformation. When the pH was increased to 7 
4.09 about 50% of the insoluble α-helix conformations transformed into a linear 8 
random-coil conformation. At pH 6.0, all the intra-molecular hydrogen bonding 9 
was disrupted and a complete change in conformation was seen from α -helix to 10 
random-coils (Delete). This property of γ-PGA is possibly useful for protecting 11 
probiotic bacteria in highly acidic gastric juice environment (pH 2.0). Moreover, 12 
and importantly for the intestinal delivery of probiotics, as γ-PGA reaches the 13 
intestine (pH ~ 6.0 - 6.5)  the polymer should disintegrate because of the 14 
disruption of hydrogen bonds (Ho et al., 2006) leading to the release of the 15 
bacteria into the target site. 16 
 17 
 18 
 19 
 20 
5. CONCLUSIONS 21 
This research has shown that γ-PGA can be successfully used to immobilise 22 
probiotic Bifidobacterium strains and improve their survival during storage in 23 
acidic fruit juices, such as orange and pomegranate juice. This offers the 24 
opportunity to use fruit juices as alternatives to dairy products for probiotic 25 
22 
 
delivery. This would be particularly beneficial for individuals who are lactose 1 
intolerant or are allergic to milk proteins, as dairy products are presently the 2 
major sources for probiotic delivery. In addition, γ-PGA can potentially protect 3 
Bifidobacterium strains against the acidic conditions of the stomach during 4 
gastrointestinal tract passage. This study, along with our previous work, suggests 5 
that γ-PGA could potentially be used as a single protective agent for probiotic 6 
bacteria during freeze drying, storage in fruit juices and during transit through 7 
the gastrointestinal tract.  8 
 9 
Future work must include the protection of probiotic cells by γ-PGA in bile salt 10 
as well as their release in the intestine and subsequent colonisation of the host. 11 
Thus γ-PGA could have the potential to facilitate the effective delivery of 12 
sufficient numbers of viable probiotic bacteria to the gastrointestinal target sites 13 
leading to successful colonisation, which is important for delivering beneficial 14 
health effects (Delete).  15 
 16 
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